External reference pricing in Europe: the basics, and why list prices ripple

What it is

External reference pricing (ERP), also called international reference pricing, sets or caps the price of a medicine in one country by reference to its price in a basket of other countries. The authority collects the ex-factory (occasionally wholesale) prices of the same product in the basket, applies a formula, and uses the result as the maximum price, the starting point for negotiation, or a check on a price the company proposes.

Most EU member states use it in some form; the exceptions are few and mostly the largest markets, where negotiation or free pricing with reimbursement controls dominates.

How a basket works

Three choices define a country’s system:

• The basket: which countries are referenced. Small, lower-income countries tend to reference their neighbours and the big markets; large markets reference each other.
• The formula: the lowest price in the basket, the average, an average of the three lowest, or a weighted figure adjusted for purchasing power.
• The frequency: at launch only, or re-referenced every year or two, so that price cuts abroad flow through.

Examples of the pattern (to be verified against each country’s current rules before publication): the Netherlands caps prices at the average of a small basket of neighbouring and comparable countries, revised twice a year; Spain and several Central and Eastern European countries take the lowest, or an average of the lowest, in a wider basket; France references Germany, Italy, Spain and the UK informally in negotiation; Germany and the UK do not set prices by ERP, though Germany’s AMNOG negotiations take European prices into account.

Why prices ripple

Because baskets overlap, a price in one country is an input to many others. A cut in a small market that sits in several baskets lowers the referenced average elsewhere, which triggers re-referencing, which lowers further baskets. Manufacturers therefore:

• launch first in countries with higher accepted prices and delay or decline launch in low-price countries that are widely referenced;
• defend list prices and give value through confidential discounts instead, which do not enter the baskets (hence the gap between list and net);
• align pack sizes and presentations so that cross-country comparison is harder.

Payers respond by referencing net prices where they can see them, by adjusting for purchasing power, and by sharing data through EURIPID.

What it means for parallel trade

ERP compresses list-price differentials over time but never closes them: formulas lag, currencies move, baskets differ and some countries stay outside. The persistent differentials that remain are structural (purchasing power, margins, VAT, exchange rates) rather than accidental, and they are where parallel trade lives. A trader reading a country’s ERP rules can see which way its prices will move at the next re-referencing and which products are most exposed.

What it means for launch planning

For a new product, the order of European launches is partly an ERP question: which countries’ prices will be referenced by which others, and when. For a generic, the originator’s referenced price and the destination’s reference-price groups set the ceiling the generic competes under.

What to check for a country

1. Does it use ERP for the product category (reimbursed, hospital, generics)?
2. The basket, the formula and the re-referencing cycle.
3. Which price type is referenced (ex-factory, usually) and how currencies are converted.
4. Whether confidential discounts are visible to it (through EURIPID or bilateral agreements).

The country guides on this site set this out per market, and MPA’s prices dataset holds the published ex-factory prices that feed the baskets.